(2023). Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques. Stat Med. http://doi.org/10.1002/sim.9771.
(2023). Determining cardiovascular risk in patients with unattributed chest pain in UK primary care: an electronic health record study. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwad055.
(2023). Risk of venous thromboembolism with gout flares. Arthritis Rheumatol. http://doi.org/10.1002/art.42480.
Musculoskeletal pain and its impact on prognosis following acute coronary syndrome or stroke: A linked electronic health record cohort study. Musculoskeletal Care, 1– 14. http://doi.org/https://doi.org/10.1002/msc.1748.
(2022). Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes. Diabetes Care, 45, 2737-2745. http://doi.org/10.2337/dc22-0894.
(2022). Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout. Jama, 328, 440-450. http://doi.org/10.1001/jama.2022.11390.
(2022). Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals. Lancet Reg Health Eur, 17, 100386. http://doi.org/10.1016/j.lanepe.2022.100386.
(2022). Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study. Plos Med, 19, e1004003. http://doi.org/10.1371/journal.pmed.1004003.
(2022). Long-Term Cardiovascular Risk and Management of Patients Recorded in Primary Care With Unattributed Chest Pain: An Electronic Health Record Study. J Am Heart Assoc, 11, e023146. http://doi.org/10.1161/jaha.121.023146.
(2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1113.